| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |